Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Diederich

Showing results (51-60 of 248) with videos related to

Pageof 25
Sort By:
Biochemical Pharmacology|November 11, 2019
Epigenetic mechanisms underlying the therapeutic effects of HDAC inhibitors in chronic myeloid leukemiaManon Lernoux, Michael Schnekenburger, Mario Dicato, et al.
Cancer Letters|October 2, 2013
Antiproliferative and proapoptotic activities of 4-hydroxybenzoic acid-based inhibitors of histone deacetylasesCarole Seidel, Michael Schnekenburger, Mario Dicato, et al.
Genes & Nutrition|January 26, 2012
Dietary compounds as potent inhibitors of the signal transducers and activators of transcription (STAT) 3 regulatory networkAnne Trécul, Franck Morceau, Mario Dicato, et al.
Biochemical Pharmacology|February 21, 2012
MicroRNAs in cancer management and their modulation by dietary agentsTommy Karius, Michael Schnekenburger, Mario Dicato, et al.
Journal of Experimental Therapeutics & Oncology|February 1, 2011
Targeting inflammatory cell signaling mechanisms: a promising road to new therapeutic agents in chemoprevention and cancer therapyMichael Schnekenburger, Tommy Karius, Claudia Cerella, et al.
Biotechnology Advances|March 5, 2011
Gold from the sea: marine compounds as inhibitors of the hallmarks of cancerMarc Schumacher, Mareike Kelkel, Mario Dicato, et al.
Biochemical Pharmacology|July 10, 2010
Targeting COX-2 expression by natural compounds: a promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapyClaudia Cerella, Cyril Sobolewski, Mario Dicato, et al.
Biochemical Pharmacology|May 23, 2006
RETRACTED: Glutathione as a mediator of apoptotic cell signaling pathwaysSilvia Cristofanon, Mario Dicato, Lina Ghibelli, et al.
Free Radical Biology & Medicine|January 15, 2019
Redox biology of regulated cell death in cancer: A focus on necroptosis and ferroptosisCristina Florean, Sungmi Song, Mario Dicato, et al.
Current Topics in Medicinal Chemistry|October 14, 2015
Novel Pharmaceutical Approaches by Natural Compound-Derived Epigenetic Regulators: Epigenetic Readers, Writers and Erasers as Therapeutic TargetsMichael Schnekenburger, Cristina Florean, Cindy Grandjenette, et al.
Pageof 25

Showing results (51-60 of 248) with videos related to

Sort By:
Pageof 25
Biochemical Pharmacology|November 11, 2019
Epigenetic mechanisms underlying the therapeutic effects of HDAC inhibitors in chronic myeloid leukemiaManon Lernoux, Michael Schnekenburger, Mario Dicato, et al.
Cancer Letters|October 2, 2013
Antiproliferative and proapoptotic activities of 4-hydroxybenzoic acid-based inhibitors of histone deacetylasesCarole Seidel, Michael Schnekenburger, Mario Dicato, et al.
Genes & Nutrition|January 26, 2012
Dietary compounds as potent inhibitors of the signal transducers and activators of transcription (STAT) 3 regulatory networkAnne Trécul, Franck Morceau, Mario Dicato, et al.
Biochemical Pharmacology|February 21, 2012
MicroRNAs in cancer management and their modulation by dietary agentsTommy Karius, Michael Schnekenburger, Mario Dicato, et al.
Journal of Experimental Therapeutics & Oncology|February 1, 2011
Targeting inflammatory cell signaling mechanisms: a promising road to new therapeutic agents in chemoprevention and cancer therapyMichael Schnekenburger, Tommy Karius, Claudia Cerella, et al.
Biotechnology Advances|March 5, 2011
Gold from the sea: marine compounds as inhibitors of the hallmarks of cancerMarc Schumacher, Mareike Kelkel, Mario Dicato, et al.
Biochemical Pharmacology|July 10, 2010
Targeting COX-2 expression by natural compounds: a promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapyClaudia Cerella, Cyril Sobolewski, Mario Dicato, et al.
Biochemical Pharmacology|May 23, 2006
RETRACTED: Glutathione as a mediator of apoptotic cell signaling pathwaysSilvia Cristofanon, Mario Dicato, Lina Ghibelli, et al.
Free Radical Biology & Medicine|January 15, 2019
Redox biology of regulated cell death in cancer: A focus on necroptosis and ferroptosisCristina Florean, Sungmi Song, Mario Dicato, et al.
Current Topics in Medicinal Chemistry|October 14, 2015
Novel Pharmaceutical Approaches by Natural Compound-Derived Epigenetic Regulators: Epigenetic Readers, Writers and Erasers as Therapeutic TargetsMichael Schnekenburger, Cristina Florean, Cindy Grandjenette, et al.
Pageof 25